Immune checkpoint inhibitors can be effective treatments for elderly people with some types of advanced cancer, but more information is needed on their risks and benefits in this group.
by Emma Yasinski
Uterine cancer incidence is increasing in the U.S., particularly in Hispanic, Asian and black women, but obesity may play a smaller role in this change than was previously assumed.
by Ashley P. Taylor
For the first time, people living in the Navajo Nation who are diagnosed with cancer can get treated for the disease without leaving tribal lands.
by Kate Yandell
FROM THE EDITOR-IN-CHIEF
DNA sequencing of blood cells may provide clues for how cancer and other illnesses develop.
by William G. Nelson, MD, PhD
Researchers want to find out when cancer patients can benefit from receiving lower doses of drugs or radiation, shortening treatment or skipping certain treatments altogether.
FORWARD LOOK
Irene Ghobrial on studying cancer precursors.
by Sue Rochman
At-home genetic tests offer limited information on cancer risk.
by Sharon Tregaskis
Proton therapy, an alternative to standard radiation therapy, is safe and effective. But evidence is lacking that it’s always a better option than standard radiation, and some insurers balk at the higher price tag.
E-cigarettes are upending decades of smoke-free successes.
by Nancy Averett
Some patients report unusual side effects after scans.
by Stephen Ornes
Minister and thyroid cancer survivor Thurselle C. Williams speaks at conferences and events about cancer awareness and, ultimately, healing following her 2016 diagnosis.
by Erin L. Boyle
A survey finds many patients prefer talking through imaging findings related to cancer with their physician rather than viewing reports online—but only if the wait for results is short.
by Cindy Kuzma
Hillary Stires writes about a conversation with a patient advocate that changed how she thought about her work.
The U.S. Food and Drug Administration has approved a second targeted therapeutic based on tumor biomarker, not tumor origin.
A congressional briefing provided information on vaccination, screening and treatment for cancers caused by the human papillomavirus.
A Lesson in Service
donate to the AACR